Pharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
Pharmcore Inc. is recalling 3,070 vials of Human Chorionic Gonadotropin 2500 IU due to a lack of assurance of sterility. The recall is nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility for an injectable drug, which poses a significant risk of infection and potential hospitalization.
Plain-English summary
Pharmcore Inc. is recalling 3,070 vials of Human Chorionic Gonadotropin 2500 IU Vial Lyophilized. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected lots are HCG25112 (Exp. 2/28/2019), HCG25110 (Exp. 1/31/2019), HCG25115 (Exp. 4/30/2019), HCG25114 (Exp. 4/30/2019), and HCG25111 (Exp. 2/28/2019). The product was distributed nationwide.
Consumers and healthcare providers should stop using the recalled product and contact Pharmcore Inc. or their healthcare provider for further instructions.
The recalled product
- Product
- Human Chorionic Gonadotropin 2500 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
- Manufacturer
- Pharmcore Inc.
- Category
- Drug — Injectable
- Affected units
- 3,070
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lots: HCG25112 Exp. 2/28/2019
- HCG25110 Exp. 1/31/2019
- HCG25115 Exp. 4/30/2019
- HCG25114 Exp. 4/30/2019
- HCG25111 Exp. 2/28/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 9 recalled by Pharmcore Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · Pharmcore Inc.
See all →- SeverePharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Methylcobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
Same hazard · infection
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- HighSurgipro Sutures Recalled for Potential Sterile Barrier Perforation
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19